Register
Pink Sheets Markets Today:
May 17, 2013 total dollar volume
$180,854,280
Author:
By Martin Tsvetkov
Feb 16, 2011

The Sub-Penny Stock of Simulated Environment Concepts Inc (SMEV.PK) Fails To Live Up To Expectations

SMEV chart.pngDespite having been a subject of heavy promotion for the last two months, the market performance of the stock of Simulated Environment Concepts Inc. (PINK:SMEV) has been far from impressive. During yesterday's trading session, the price of SMEV stock did nothing spectacular, closing at $0.0023 per share. The turnover, on the other hand, marked a significant decrease over the day before as only 1 million shares changed hands.

The subpar market behaviour of SMEV stock could not be altered by the CEO's shareholder address that took place two weeks ago. Although it outlined a record-breaking performance of the company's SpaCapsule, as well as its firm intention to upgrade its OTC market status, it still dos not appear convincing enough to boost price and volume.

The company's latest Q3 report covering the period ended Sept. 30, 2010 shows:

  • a 92% increase of outstanding stock;
  • 11 billion of authorized stock;
  • float of 99 million;
  • an operating net loss exceeding $0.5 million - a 175% increase over Q2.

While the current financial state of SMEV seems fairly fragile, the company actually has a final product - the so called SpaCapsule. Moreover, last year it signed an agreement with an European distributor for the sale of 250 units. The product has already been shipped to a number of countries. According to a lot of investors, all SMEV needs is an effective PR campaign in order to make it.

What does the future have in store for SMEV? If you ask CEO Ella Frenkel, the company is on its way to expansion and there is no turning back. At least till the next shareholder address scheduled for March 4. 

SMEV logo.jpg

Average Reader Price Target For SMEV:

Going Up!
0.0039

What price do you think this stock will go to?

Reader Valuation Chart

Article Comments:

Guest wrote: 3:48 pm Feb 16, 2011
As a shareholder I have been talking with other shareholders to get the company to address the A/S issue. We h
ave been trying to make it clear that disolving the A/S to say 300b would allow investors more confidence
and to assist in preventing (perhaps further) dilution. I believe the last reported float was low say 99
m I recall. We have welcomed the CEOs calls for transparency and furthermore look very forward to them be
coming fully reporting which the company has outlined by Q2 2011 per past prs. We would like to know what
the fincials realy are and if they are profitable. certainly as a shareholder I feel it would increase c
ompany value and confidence as well if we were trading on a higher exchange! ONLY MY OPINION I
dr_c6 wrote: 6:59 pm Feb 16, 2011
Reduce A/S shares, become fully reporting, submit FDA applications, show profitability or steps to reduce oper
ating loss, and get a pr campaign going for these things, and we're in business. No one is really interes
ted right

Comment: